Related Experiment Video
Updated: Jul 25, 2025

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
Published on: December 3, 2017
It can be unnecessary to combine common synovial fluid analysis and alpha-defensin tests for periprosthetic joint
Hao Li1,2,3, Rui Li2,3, Niu Erlong4
1Medical School of Chinese PLA, Beijing, People's Republic of China.
Background:
Periprosthetic joint infection is a serious complication after total joint arthroplasty. Despite that alpha-defensin was used as diagnostic test in the 2018 ICM (international consensus meeting) criteria, its position in the PJI diagnostic pipeline was controversial. Therefore, we performed a retrospective pilot study to identify whether synovial fluid alpha-defensin test was necessary when corresponding synovial fluid analysis (WBC count, PMN% and LE tests) was performed.
Methods:
Between May 2015 and October 2018, a total of 90 suspected PJI patients who underwent revisions after TJA were included in this study. Based on the 2018 ICM criteria, the interobserver agreements between preoperative diagnostic results and postoperative diagnostic results and the interobserver reliability between preoperative diagnostic results and postoperative diagnostic results with or without synovial fluid alpha-defensin tests were calculated. After that, the ROC analysis, and the direct cost-effectiveness of adding alpha-defensin was performed.
Results:
There were 48,16 and 26 patients in the PJI group, inconclusive group and non-PJI group, respectively. Adding the alpha-defensin tests into 2018 ICM criteria can't change the preoperative diagnostic results, postoperative diagnostic results, and the concordance between preoperative and postoperative diagnostic results. Moreover, the Risk-benefit Ratio is over 90 per changed decision and the direct cost-effectiveness of alpha-defensin was more than $8370($93*90) per case.
Conclusions:
Alpha-defensin assay exhibit high sensitivity and specificity for PJI detection as a standalone test based on the 2018 ICM criteria. However, the additional order of Alpha-defensin can't offer additional evidence for PJI diagnosis when corresponding synovial fluid analysis was performed (synovial fluid WBC count, PMN% and LE strip tests).
Evidence Level:
Level II, Diagnostic study.
Insights
The alpha-defensin test does not improve periprosthetic joint infection (PJI) diagnosis when standard synovial fluid analysis is already performed. Adding this test offers no additional diagnostic value for PJI.
Area of Science:
- Orthopedic Surgery
- Infectious Diseases
- Diagnostic Medicine
Background:
- Periprosthetic joint infection (PJI) is a significant complication following total joint arthroplasty.
- The diagnostic role of synovial fluid alpha-defensin in PJI, despite its inclusion in the 2018 International Consensus Meeting (ICM) criteria, remains debated.
- This study evaluated the necessity of alpha-defensin testing when standard synovial fluid analyses are conducted.
Purpose of the Study:
- To determine if synovial fluid alpha-defensin testing provides additional diagnostic value for periprosthetic joint infection (PJI) when routine synovial fluid analysis is performed.
- To assess the impact of adding alpha-defensin testing on diagnostic concordance and cost-effectiveness in suspected PJI cases.
Main Methods:
- A retrospective pilot study included 90 patients with suspected PJI undergoing revision arthroplasty.
- Interobserver agreements and reliability were calculated based on the 2018 ICM criteria, with and without alpha-defensin testing.
- Receiver operating characteristic (ROC) analysis and cost-effectiveness evaluation were performed.
Main Results:
- Adding alpha-defensin testing did not alter preoperative or postoperative PJI diagnostic results or the concordance between them.
- The risk-benefit ratio exceeded 90 per changed decision, indicating limited added benefit.
- The direct cost-effectiveness of alpha-defensin was calculated to be over $8370 per case.
Conclusions:
- Alpha-defensin assays are sensitive and specific for PJI detection as a standalone test under the 2018 ICM criteria.
- However, additional alpha-defensin testing offers no supplementary evidence for PJI diagnosis when standard synovial fluid analyses (WBC count, PMN%, LE strip tests) are already completed.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Structural Joints: Synovial Joints
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urine Studies II: Urine Culture and Sensitivity Test
Acute Pyelonephritis I: Introduction
Pneumonia III: Complications and Assessment

